Search research articles
Contact Us
Filters
Showing results (231-240 of 277) with videos related to
Page
of 28
Sort By:
JMIR Public Health and Surveillance
|
March 24, 2021
Automated Travel History Extraction From Clinical Notes for Informing the Detection of Emergent Infectious Disease Events: Algorithm Development and Validation
Kelly S Peterson, Julia Lewis, Olga V Patterson, et al.
Gene Therapy
|
June 27, 2002
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours
A V Patterson, K J Williams, R L Cowen, et al.
JAMA Network Open
|
April 11, 2022
Demographic Differences Among US Department of Veterans Affairs Patients Referred for Genetic Consultation to a Centralized VA Telehealth Program, VA Medical Centers, or the Community
Maren T Scheuner, Alexis K Huynh, Catherine Chanfreau-Coffinier, et al.
Biochemistry
|
August 13, 2019
Engineering <i>Escherichia coli</i> NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy
Elsie M Williams, Michelle H Rich, Alexandra M Mowday, et al.
British Journal of Cancer
|
July 20, 2000
Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha
J P Braybrooke, D J Propper, K J O'Byrne, et al.
Circulation. Heart Failure
|
November 14, 2019
Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/Valsartan
April F Mohanty, Emily B Levitan, John A Dodson, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2021
Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors
Wuqing Deng, Xiaojuan Chen, Kaili Jiang, et al.
Science (New York, N.Y.)
|
September 28, 2013
Product-to-parent reversion of trenbolone: unrecognized risks for endocrine disruption
Shen Qu, Edward P Kolodziej, Sarah A Long, et al.
European Journal of Medicinal Chemistry
|
February 16, 2018
Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer
Qiuping Xiang, Chao Wang, Yan Zhang, et al.
Journal of Medicinal Chemistry
|
May 28, 2026
Discovery of a Highly Potent and Efficient BRD9 Degrader with Strong <i>In Vivo</i> Antitumor Activity
Xin Tang, Yumin Huang, Cheng Zhang, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 277) with videos related to
Sort By:
Page
of 28
JMIR Public Health and Surveillance
|
March 24, 2021
Automated Travel History Extraction From Clinical Notes for Informing the Detection of Emergent Infectious Disease Events: Algorithm Development and Validation
Kelly S Peterson, Julia Lewis, Olga V Patterson, et al.
Gene Therapy
|
June 27, 2002
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours
A V Patterson, K J Williams, R L Cowen, et al.
JAMA Network Open
|
April 11, 2022
Demographic Differences Among US Department of Veterans Affairs Patients Referred for Genetic Consultation to a Centralized VA Telehealth Program, VA Medical Centers, or the Community
Maren T Scheuner, Alexis K Huynh, Catherine Chanfreau-Coffinier, et al.
Biochemistry
|
August 13, 2019
Engineering <i>Escherichia coli</i> NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug Therapy
Elsie M Williams, Michelle H Rich, Alexandra M Mowday, et al.
British Journal of Cancer
|
July 20, 2000
Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha
J P Braybrooke, D J Propper, K J O'Byrne, et al.
Circulation. Heart Failure
|
November 14, 2019
Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/Valsartan
April F Mohanty, Emily B Levitan, John A Dodson, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2021
Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors
Wuqing Deng, Xiaojuan Chen, Kaili Jiang, et al.
Science (New York, N.Y.)
|
September 28, 2013
Product-to-parent reversion of trenbolone: unrecognized risks for endocrine disruption
Shen Qu, Edward P Kolodziej, Sarah A Long, et al.
European Journal of Medicinal Chemistry
|
February 16, 2018
Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer
Qiuping Xiang, Chao Wang, Yan Zhang, et al.
Journal of Medicinal Chemistry
|
May 28, 2026
Discovery of a Highly Potent and Efficient BRD9 Degrader with Strong <i>In Vivo</i> Antitumor Activity
Xin Tang, Yumin Huang, Cheng Zhang, et al.
Page
of 28